Business Standard

Metropolis Healthcare advances 14%, hits new high on healthy Q4 results

The company's Q4 reported Ebitda margins expanded by 820 bps YoY at 33.2 per cent on the back of increased scale of business, strong cost optimization and automation efforts

Metropolis
Premium

Metropolis

SI Reporter Mumbai
Shares Metropolis Healthcare rallied 14 per cent to Rs 2,613 on the BSE in intra-day trade on Friday after the company reported nearly four-fold jump in consolidated net profit at Rs 61.3 crore in the March quarter (Q4FY21), on the back of healthy operational performance. The company, a leading diagnostic service provider, had profit of Rs 15.5 crore in the year-ago quarter. The stock surpassed its previous high of Rs 2,605, touched on May 12, 2021.

Revenue from operations grew 42 per cent year on year (YoY) at Rs 291.80 crore in Q4FY21, against Rs 206.10 crore in the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in